[PDF] Placebo And Nocebo Effects In Psychiatry And Beyond eBook
Placebo And Nocebo Effects In Psychiatry And Beyond Book in PDF, ePub and Kindle version is available to download in english. Read online anytime anywhere directly from your device. Click on the download button below to get a free pdf file of Placebo And Nocebo Effects In Psychiatry And Beyond book. This book definitely worth reading, it is an incredibly well-written.
This eBook is a collection of articles from a Frontiers Research Topic. Frontiers Research Topics are very popular trademarks of the Frontiers Journals Series: they are collections of at least ten articles, all centered on a particular subject. With their unique mix of varied contributions from Original Research to Review Articles, Frontiers Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author by contacting the Frontiers Editorial Office: frontiersin.org/about/contact.
A placebo is anything that looks like a real medical treatment but is not, in reality. Placebos are medical substances that improve the health status of the person due to the patient's belief that the substance is indeed effective. The opposite of the placebo effect is the nocebo effect. A nocebo is a medical substance with no medical effects that worsens the health status of the person due to the patient's negative beliefs and expectations. In psychiatry, the placebo effect plays a significant role in the majority of mental disorders, including depression, anxiety, addictions, and schizophrenia. A few prominent symptoms of nocebo effect are nausea, itching, bloating and sleeping issues. This book is a compilation of the works of various international experts carrying out research with respect to placebos and nocebo, and their significance in clinical psychiatry. It is a vital tool for all researching or studying placebo and nocebo effects.
Due to the recent explosion of placebo research at many levels the Editors believe that a volume on Placebo would be a good addition to the Handbook of Experimental Pharmacology series. In particular, this volume will be built up on a meeting on Placebo which will be held in Tuebingen (Germany) in January 2013, and where the most prominent researchers in this field will present and exchange their ideas. The authors who will be invited to write chapters for this volume will be the very same speakers at this meeting, thus guaranteeing high standard and excellence in the topic that will be treated. The approach of the book is mainly pharmacological, including basic research and clinical trials, and the contents range from different medical conditions and systems, such as pain and the immune system, to different experimental approaches, like in vivo receptor binding and pharmacological/behavioral conditioning. Overall, the volume will give an idea of modern placebo research, of timely concepts in both experimental and clinical pharmacology, as well as of modern methods and tools in neuroscience.
This book provides a perspective on the concepts placebo and placebo effects, which has been missing so far: a detailed analysis of the history of the terms, their current use, suggested alternatives and the implications of the conceptual confusion. Everybody knows something about placebos and placebo effects. If, however, people are asked to define the concepts, the spectrum becomes wide. Does 'placebo' refer to an inert treatment or does it cover all elements of the patient-physician-interaction except for pharmacological or other physiological mechanisms? Furthermore, if, by definition, a placebo has no effect, what sense does it make to talk about a 'placebo effect'? Even in scientific literature the concepts ‘placebo’ and ‘placebo effect’ are used in many senses and often in a confusing way. While this book discusses many issues which keep puzzling physicians, it also covers the historical developments of the concepts of placebo and placebo effect as well as the conceptual confusion in the definitions. This book is intended for physicians, philosophers, psychologists and any other people interested in placebos, placebo effects and the physician-patient relationship.
Author : David A. Jopling Publisher : Oxford University Press, USA Page : 333 pages File Size : 13,71 MB Release : 2008-05-29 Category : Medical ISBN : 0199239509
Psychodynamic psychotherapy and psychoanalysis have had to defend themselves from a barrage of criticisms throughout their history. In this book David Jopling argues that the changes achieved through therapy are really just functions of placebos that rally the mind's native healing powers. It is a bold new work that delivers yet another blow to Freud and his followers.
Do antidepressants work? Of course -- everyone knows it. Like his colleagues, Irving Kirsch, a researcher and clinical psychologist, for years referred patients to psychiatrists to have their depression treated with drugs before deciding to investigate for himself just how effective the drugs actually were. Over the course of the past fifteen years, however, Kirsch's research -- a thorough analysis of decades of Food and Drug Administration data -- has demonstrated that what everyone knew about antidepressants was wrong. Instead of treating depression with drugs, we've been treating it with suggestion. The Emperor's New Drugs makes an overwhelming case that what had seemed a cornerstone of psychiatric treatment is little more than a faulty consensus. But Kirsch does more than just criticize: he offers a path society can follow so that we stop popping pills and start proper treatment for depression.
This book is the second of the series about the imperatives for the search for new psychiatry. As stated in my recent 2021 book about: The Search for New Psychiatry, current psychiatric practices have failed many: patients and their families, their doctors and the society at large. That was the end of the 2021 book and the beginning of this book as a follow up in search for pathways to a new and more effective science-based practice Based on its major contributions to the recent successful and expedient development of the Covid 19 vaccines, I am proposing the same pathway of using the new revolution in informatics as the way to save and secure the future of psychiatry and that is what I am recommending in this book reaping the benefit of AI and Big Data Analytics but with a wide open eye on its limits, reliability, risks, unforeseen or unintentional harms. Part Two of the book deals with a number of perineal and also new challenges that continue to require better understanding and resolution. Among the phenomenological and nosological challenges, the recent development by Neurology of its subspeciality of Behavioral Neurology in competition to Neuropsychiatry, is reviewed in terms of an opportunity for integration of the tow subspecialities towards the creation of a new third field of “Clinical Neurosciences”. Other challenges included are: The Subjective /Objective Dichotomy, Lunacy and the Moon- reflections on the interactions of the brain and environment and Woke Psychiatry, what is it? Several other clinical challenges include: The Past is Coming Back as The Future -The Rise, Fall and Rise Again of Psychedelics, Loneliness as the silent disorder and several other challenges. At the end, a postscript has been hastily added in memory of a close friend, a pioneering psychopharmacologist but above all an empathic humanist, Professor Thomas Arthur Ban or as he always preferred, Tom.
Celebrating 100 years of HEP, this volume will discuss key pharmacological discoveries and concepts of the past 100 years. These discoveries have dramatically changed the medical treatment paradigms of many diseases and these concepts have and will continue to shape discovery of new medicinies. Newly evolving technologies will similarly be discussed as they will shape the future of the pharmacology and, accordingly, medical therapy.
Based on a meeting in November 2000, this book brings together researchers from a wide range of disciplines to examine the biological, behavioral, social, cultural and ethical aspects related to the placebo effect. Perspectives on the necessity for including a placebo in randomized clinical trials will also be examined. This is the first attempt to examine the evidence-base of the placebo effect and will provide important information for clinicans.
"The troubling increase in treatment resistance in psychiatry has many culprits: the rise of biomedical psychiatry and corresponding sidelining of psychodynamic and psychosocial factors; the increased emphasis on treating the symptoms rather than the person; and a greater focus on the electronic medical record rather than the patient, all of which point to a breakdown in the person-centered prescriber-patient relationship. Psychodynamic Psychopharmacology illuminates a new path forward. It examines the psychological and interpersonal mechanisms of pharmacological treatment resistance, integrating research on evidence-based prescribing processes with psychodynamic insights and skills to enhance treatment outcomes for patients who are difficult to treat. The first part of the book explores the evidence base that guides how, rather than simply what, to prescribe. It describes precisely what psychodynamic psychopharmacology is and why its emphasis on combining the often-neglected psychosocial aspects of medication with biomedical considerations provides a more optimized approach to addressing treatment resistance. Part II delves into the psychodynamics that contribute to pharmacological treatment resistance, both when patients' ambivalence about their illness, the medication itself, or their prescriber manifests in nonadherence and when medications support a negative identity or are used as replacements for healthy capacities. Readers will gain basic skills for addressing the psychological and interpersonal dynamics that underpin both scenarios and will be better positioned to ameliorate interferences with the healthy use of medications. The final section of the book offers detailed technical recommendations for addressing pharmacological treatment resistance. It tackles issues that include countertransference-driven irrational prescribing; primitive dynamics, such as splitting and projective identification; and the overlap between psychopharmacological treatment resistance and the dynamics of treatment nonadherence and nonresponse in integrated and collaborative medical care settings. By putting the individual patient back at the center of the therapeutic equation, psychodynamic psychopharmacology, as outlined in this book, offers a model that moves beyond compliance and emphasizes instead the alliance between patient and prescriber. In doing so, it empowers patients to become more active contributors in their own recovery"--